ABLYNX ANNOUNCES WEBCAST OF ITS PRESENTATION AT THE ANNUAL JEFFERIES 2012 GLOBAL HEALTHCARE CONFERENCE

(Thomson Reuters ONE) -


GHENT, Belgium, 30 May 2012 - Ablynx [Euronext Brussels: ABLX] today announced
that it will webcast its corporate presentation at the annual Jefferies 2012
Global Healthcare Conference on Monday, 4 June 2011 at 04:30 p.m. EST / 10.30
p.m. CET.

The presentation, followed by a Q&A, will be hosted by Dr Edwin Moses, CEO and
Chairman of Ablynx. The presentation will be webcast live and may be accessed on
the home page of Ablynx's website at www.ablynx.com. A replay of the webcast
will also be available on the Company's website for 30 days following the
presentation.

To ensure a timely connection, it is recommended that participants register a
few minutes prior to the live webcast.


About Ablynx

Ablynx is a biopharmaceutical company engaged in the discovery and development
of Nanobodies(®), a novel class of therapeutic proteins based on single-domain
antibody fragments, for a range of serious and life-threatening human diseases,
including inflammation, haematology, oncology and pulmonary disease. Today, the
Company has over 25 programmes in the pipeline and seven Nanobodies at clinical
development stage. Ablynx has ongoing research collaborations and significant
partnerships with major pharmaceutical companies, including Boehringer
Ingelheim, Merck Serono, and Novartis. The Company is headquartered in Ghent,
Belgium. More information can be found on www.ablynx.com.



For more information, please contact

Ablynx:
Dr Edwin Moses
Chairman and CEO
t:   +32 (0)9 262 00 07
m: +44 (0)7771 954 193 /
     +32 (0)473 39 50 68
e:  edwin.moses(at)ablynx.com

Marieke Vermeersch
Investor Relations Manager
t:   +32 (0)9 262 00 82
m: +32 (0)479 49 06 03
e:  marieke.vermeersch(at)ablynx.com

M:Communications:

Mary-Jane Elliott, Amber Bielecka, Claire Dickinson
t:   +44 207 920 2330
e:  ablynx(at)mcomgroup.com




Press release in pdf version:
http://hugin.info/137912/R/1615746/515142.pdf



This announcement is distributed by Thomson Reuters on behalf of
Thomson Reuters clients. The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and
other applicable laws; and
(ii) they are solely responsible for the content, accuracy and
originality of the information contained therein.

Source: Ablynx via Thomson Reuters ONE
[HUG#1615746]

Weitere Infos zu dieser Pressemeldung:
Unternehmensinformation / Kurzprofil:
Bereitgestellt von Benutzer: hugin
Datum: 30.05.2012 - 08:01 Uhr
Sprache: Deutsch
News-ID 151066
Anzahl Zeichen: 2800

contact information:
Town:

Ghent

Kategorie:

Business News

Diese Pressemitteilung wurde bisher 130 mal aufgerufen.


Die Pressemitteilung mit dem Titel:
"ABLYNX ANNOUNCES WEBCAST OF ITS PRESENTATION AT THE ANNUAL JEFFERIES 2012 GLOBAL HEALTHCARE CONFERENCE"
steht unter der journalistisch-redaktionellen Verantwortung von

Ablynx (Nachricht senden)

Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).

Publication in Accordance With Article 14 of the Belgian Law of 2 May 2007 Regar ...

GHENT, BELGIUM -- (Marketwired) -- 08/27/13 -- (EURONEXT BRUSSELS: ABLX) today announced, in accordance with Article 14 of the Belgian Law of 2 May 2007 regarding the publication of major shareholdings in issuers whose securities are admitted to tr ...

Ablynx Announces Half-Year Results for 2013 ...

GHENT, BELGIUM -- (Marketwired) -- 08/21/13 -- (EURONEXT BRUSSELS: ABLX) today announced its results for the six-month period ending 30 June 2013, which have been prepared in accordance with the IAS 34 "Interim Financial Reporting" as adop ...

Ablynx Announces Warrant Exercise ...

GHENT, BELGIUM -- (Marketwired) -- 07/23/13 -- (EURONEXT BRUSSELS: ABLX) today announced, in conformity with Title II of the Law of 2 May 2007 and the Royal Decree of 14 February 2008, that an additional 273,913 common shares have been issued by the ...

Alle Meldungen von Ablynx